Advertisement
Screener

DBV Technologies S.A. (DBVT) Spending and interest coverage

DBV Technologies S.A. (DBVT) Spending and interest coverage

  • R&D / revenue · 12 months: Value 2503.61%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 168.53%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months2503.61%Research and development expense / revenue. Period ending 2026-06-30.

$126.08M ÷ $5.04M × 100 ≈ 2503.61%

Stock-based compensation / revenue · 12 months168.53%Share-based compensation / revenue. Period ending 2026-06-30.

$8.49M ÷ $5.04M × 100 ≈ 168.53%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending126.08M USDResearch and Development Expense
Revenue5.04M USD
Stock-based compensation8.49M USDShare-based Payment Arrangement, Noncash Expense
Operating income-177.86M USDOperating Income (Loss)
Interest expense · reported / estimated(m) · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30$126.08M$5.04M$8.49M$-177.86M(m)2503.61%168.53%(m)(m)
2026-03-31$128.58M$5.74M$5.99M$-168.36M(m)2241.67%104.38%(m)(m)
2025-12-31$116.68M$5.64M$5.39M$-147.06M(m)2070.30%95.58%(m)(m)
2025-09-30$102.69M$5.50M$3.01M$-125.87M(m)1866.48%54.71%(m)(m)
2025-06-30$97.74M$3.80M$4.08M$-121.92M(m)2572.13%107.47%(m)(m)
2025-03-31$89.42M$3.50M$4.36M$-114.65M(m)2557.11%124.79%(m)(m)
2024-12-31$89.34M$4.15M$4.62M$-116.59M(m)2152.30%111.30%(m)(m)
2024-09-30$83.21M$12.52M$6.29M$-104.65M(m)664.91%50.28%(m)(m)
2024-06-30$73.35M$13.81M$6.06M$-92.59M(m)530.96%43.84%(m)(m)
2024-03-31$65.59M$14.94M$6.34M$-83.83M(m)438.99%42.47%(m)(m)
2023-12-31$60.22M$15.73M$6.02M$-76.43M(m)382.90%38.27%(m)(m)
2023-09-30$77.06M$5.55M$6.41M$-102.53M(m)1388.74%115.52%(m)(m)
2023-06-30$78.36M$5.25M$6.03M$-102.28M(m)1492.04%114.83%(m)(m)
2023-03-31$79.36M$4.49M$5.29M$-101.03M(m)1766.63%117.88%(m)(m)
2022-12-31$75.54M$4.84M$5.03M$-96.63M(m)1559.52%103.76%(m)(m)
2022-09-30$57.60M$9.08M$2.46M$-72.09M(m)634.39%27.09%(m)(m)
2022-06-30$58.83M$8.33M$3.04M$-78.44M(m)706.29%36.45%(m)(m)
2022-03-31$60.40M$5.31M$3.05M$-85.75M(m)1136.74%57.44%(m)(m)
2021-12-31$70.34M$5.71M$3.12M$-98.61M(m)1232.24%54.70%(m)(m)
2021-09-30$85.06M$1.56M$5.91M$-125.30M(m)5438.36%378.07%(m)(m)
2021-06-30$94.49M$4.40M$4.29M$-130.69M(m)2147.90%97.48%(m)(m)
2021-03-31$96.24M$9.50M$-2.77M$-147.25M(m)1013.36%-29.17%(m)(m)
2020-12-31$101.61M$11.28M$-1.13M$-158.84M(m)901.09%-10.02%(m)(m)
2020-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31$115.10M$14.71M$17.24M$-171.02M(m)782.59%117.21%(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.